134 related articles for article (PubMed ID: 9586059)
21. Affinity of the antiviral enantiomers of oxathiolane cytosine nucleosides for human 2'-deoxycytidine kinase.
Shewach DS; Liotta DC; Schinazi RF
Biochem Pharmacol; 1993 Apr; 45(7):1540-3. PubMed ID: 8385948
[TBL] [Abstract][Full Text] [Related]
22. Activation of deoxycytidine kinase by deoxyadenosine: implications in deoxyadenosine-mediated cytotoxicity.
Keszler G; Virga S; Spasokoukotskaja T; Bauer PI; Sasvari-Szekely M; Staub M
Arch Biochem Biophys; 2005 Apr; 436(1):69-77. PubMed ID: 15752710
[TBL] [Abstract][Full Text] [Related]
23. The structure of human deoxycytidine kinase in complex with clofarabine reveals key interactions for prodrug activation.
Zhang Y; Secrist JA; Ealick SE
Acta Crystallogr D Biol Crystallogr; 2006 Feb; 62(Pt 2):133-9. PubMed ID: 16421443
[TBL] [Abstract][Full Text] [Related]
24. Fluorescence energy transfer studies of human deoxycytidine kinase: role of cysteine 185 in the conformational changes that occur upon substrate binding.
Mani RS; Usova EV; Cass CE; Eriksson S
Biochemistry; 2006 Mar; 45(11):3534-41. PubMed ID: 16533034
[TBL] [Abstract][Full Text] [Related]
25. [Special function of deoxycytidine kinase (dCK) in the activation of chemotherapeutic nucleoside analogs and in the inhibition of cell proliferation].
Staub M
Magy Onkol; 2004; 48(3):229-34. PubMed ID: 15520873
[TBL] [Abstract][Full Text] [Related]
26. Human deoxycytidine kinase: kinetic mechanism and end product regulation.
Kim MY; Ives DH
Biochemistry; 1989 Nov; 28(23):9043-7. PubMed ID: 2557916
[TBL] [Abstract][Full Text] [Related]
27. Kinetic interaction of 5-AZA-2'-deoxycytidine-5'-monophosphate and its 5'-triphosphate with deoxycytidylate deaminase.
Momparler RL; Rossi M; Bouchard J; Vaccaro C; Momparler LF; Bartolucci S
Mol Pharmacol; 1984 May; 25(3):436-40. PubMed ID: 6203026
[TBL] [Abstract][Full Text] [Related]
28. Phosphorylation of deoxycytidine kinase on Ser-74: impact on kinetic properties and nucleoside analog activation in cancer cells.
Amsailale R; Van Den Neste E; Arts A; Starczewska E; Bontemps F; Smal C
Biochem Pharmacol; 2012 Jul; 84(1):43-51. PubMed ID: 22490700
[TBL] [Abstract][Full Text] [Related]
29. Metabolism, mitochondrial uptake and toxicity of 2', 3'-dideoxycytidine.
Rossi L; Serafini S; Schiavano GF; Casabianca A; Vallanti G; Chiarantini L; Magnani M
Biochem J; 1999 Dec; 344 Pt 3(Pt 3):915-20. PubMed ID: 10585881
[TBL] [Abstract][Full Text] [Related]
30. Structural basis for substrate promiscuity of dCK.
Sabini E; Hazra S; Ort S; Konrad M; Lavie A
J Mol Biol; 2008 May; 378(3):607-21. PubMed ID: 18377927
[TBL] [Abstract][Full Text] [Related]
31. Structural basis for feedback inhibition of the deoxyribonucleoside salvage pathway: studies of the Drosophila deoxyribonucleoside kinase.
Mikkelsen NE; Johansson K; Karlsson A; Knecht W; Andersen G; Piskur J; Munch-Petersen B; Eklund H
Biochemistry; 2003 May; 42(19):5706-12. PubMed ID: 12741827
[TBL] [Abstract][Full Text] [Related]
32. Molecular Imaging of Deoxycytidine Kinase Activity Using Deoxycytidine-Enhanced CEST MRI.
Han Z; Li Y; Zhang J; Liu J; Chen C; van Zijl PC; Liu G
Cancer Res; 2019 May; 79(10):2775-2783. PubMed ID: 30940660
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis C virus NS3 NTPase/helicase: different stereoselectivity in nucleoside triphosphate utilisation suggests that NTPase and helicase activities are coupled by a nucleotide-dependent rate limiting step.
Locatelli GA; Gosselin G; Spadari S; Maga G
J Mol Biol; 2001 Nov; 313(4):683-94. PubMed ID: 11697897
[TBL] [Abstract][Full Text] [Related]
34. Arabinosylguanine is phosphorylated by both cytoplasmic deoxycytidine kinase and mitochondrial deoxyguanosine kinase.
Rodriguez CO; Mitchell BS; Ayres M; Eriksson S; Gandhi V
Cancer Res; 2002 Jun; 62(11):3100-5. PubMed ID: 12036920
[TBL] [Abstract][Full Text] [Related]
35. Identification of residues involved in the substrate specificity of human and murine dCK.
Usova EV; Eriksson S
Biochem Pharmacol; 2002 Dec; 64(11):1559-67. PubMed ID: 12429345
[TBL] [Abstract][Full Text] [Related]
36. [18F]CFA as a clinically translatable probe for PET imaging of deoxycytidine kinase activity.
Kim W; Le TM; Wei L; Poddar S; Bazzy J; Wang X; Uong NT; Abt ER; Capri JR; Austin WR; Van Valkenburgh JS; Steele D; Gipson RM; Slavik R; Cabebe AE; Taechariyakul T; Yaghoubi SS; Lee JT; Sadeghi S; Lavie A; Faull KF; Witte ON; Donahue TR; Phelps ME; Herschman HR; Herrmann K; Czernin J; Radu CG
Proc Natl Acad Sci U S A; 2016 Apr; 113(15):4027-32. PubMed ID: 27035974
[TBL] [Abstract][Full Text] [Related]
37. Kinetic mechanism and inhibition of human liver thymidine kinase.
Ellims PH; Van der Weyden MB
Biochim Biophys Acta; 1981 Aug; 660(2):238-42. PubMed ID: 7284401
[TBL] [Abstract][Full Text] [Related]
38. Modulation of human deoxycytidine kinase activity as a response to cellular stress induced by NaF.
Csapó Z; Sasvári-Székely M; Spasokoukotskaja T; Staub M
Acta Biochim Pol; 2001; 48(1):251-6. PubMed ID: 11440177
[TBL] [Abstract][Full Text] [Related]
39. Increased ratio between deoxycytidine kinase and thymidine kinase 2 in CLL lymphocytes compared to normal lymphocytes.
Nielsen SE; Munch-Petersen B; Mejer J
Leuk Res; 1995 Jul; 19(7):443-7. PubMed ID: 7637389
[TBL] [Abstract][Full Text] [Related]
40. Recognition of 2'-deoxy-l-ribonucleoside 5'-triphosphates by human telomerase.
Yamaguchi T; Yamada R; Tomikawa A; Shudo K; Saito M; Ishikawa F; Saneyoshi M
Biochem Biophys Res Commun; 2000 Dec; 279(2):475-81. PubMed ID: 11118311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
